Abiopharma

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

New Form SCHEDULE 13G/A - MATTEL INC /DE/ <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003489 <b>Size:</b> 7 KB

New Form SCHEDULE 13G/A - CECO ENVIRONMENTAL CORP <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000231 <b>Size:</b> 13 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001213900-26-089488 <b>Size:</b> 688 KB

New Form SCHEDULE 13G/A - ASTRONICS CORP <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000229 <b>Size:</b> 13 KB

Change - Change of Catalist Sponsor: CHANGE OF CONTINUING SPONSOR

Financial Statements and Related Announcement: Half Yearly Results

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G/A - WESTAMERICA BANCORPORATION <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000227 <b>Size:</b> 13 KB

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

New Form SCHEDULE 13G/A - Nurix Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003488 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - Traws Pharma, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005209 <b>Size:</b> 16 KB

New Form SCHEDULE 13G/A - Bancorp, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000225 <b>Size:</b> 12 KB